Accelerating mRNA-Based Therapy Development With Scalable Purification Of In Vitro Transcribed mRNA

By Kelly Flook, Brian Sim, Jim Molinari, Julia Baek, Sirat Sikka, and Alejandro Becerra

mRNA GettyImages-1356994684

mRNA-based therapies have a wide range of potential, including synthetic mRNA tools used in the treatment of diseases such as cancer, stem cell therapies and infectious diseases. Current mRNA production methods require multiple purification steps and various chemicals, creating a bottleneck for some large-scale manufacturing. A new affinity chromatography resin has now been developed to address these challenges, particularly when manufacturing in vitro transcribed mRNA.

Learn more about the POROS Oligo (dT)25 resin's isolation and purification benefits and dynamic binding capacity. Achieve scalable mRNA purification process without the use of toxic chemicals.

access the Poster!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online